Optic Pathway Glioma
📧 Sign up to get email alerts when something new happens for Optic Pathway Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) [Phase 2]
Phase 2 clinical trial update evaluating CHF6467, a nerve growth factor formulation, for safety and efficacy in patients with optic pathway …
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas [Phase 1, Phase 2]
A Phase I/Phase II study evaluating mebendazole for pediatric gliomas has completed. It enrolled children with various glial tumors, includi…
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas [Phase 2]
Phase 2 trial assessing pegylated interferon alfa-2b in children with juvenile pilocytic astrocytoma and optic pathway gliomas has completed…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma [Phase 2]
Phase 2 trial evaluating low-dose or high-dose lenalidomide in children with NF1-associated recurrent pilocytic astrocytoma or optic pathway…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas [Phase 2]
Phase 2 trial of sorafenib in children and young adults with recurrent or progressive low-grade astrocytomas, including patients with neurof…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy [Phase 2]
This Phase 2, NCI-sponsored trial evaluated cilengitide in children and adolescents with recurrent or progressive high-grade glioma refracto…